Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-08-21
2007-08-21
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S274000, C544S274000
Reexamination Certificate
active
11134936
ABSTRACT:
Compounds of the following formula:in which R1, R2, A1, A2, X, Y, m, n, p, x and y are as defined herein. Also disclosed are pharmaceutical compositions each containing one or more of these compounds, and use thereof in treating enteroviral infection.
REFERENCES:
patent: 4886817 (1989-12-01), Takeda et al.
patent: 5464848 (1995-11-01), Diana
patent: 5780492 (1998-07-01), Dinsmore et al.
patent: 6706739 (2004-03-01), Shia et al.
patent: 61 053281 (1986-03-01), None
patent: 06 345714 (1994-12-01), None
patent: WO93/04060 (1993-03-01), None
patent: WO97/08150 (1997-03-01), None
patent: WO97/36892 (1997-10-01), None
Oberste, et al., J. Gen. Virology 2001, 82, 409-416, 409.
MMWR Weekly, Feb. 17, 2006, 55(06), 153-156.
Shia et al., “Design Synthesis, and Structure-Activity Relationship of Pyridyl Imidazolidinones: A Novel Class of Potent and Selective Human Enterovirus 71 Inhibitors”, pp. 1644-1655 Mar. 13, 2002 Published on web.
Chang Chih-Shiang
Chern Jyh-Haur
Lee Chung-Chi
Lee Yen-Chun
Shih Shin-Ru
Barker Michael
National Health Research Institutes
Occhivti Rohlicek & Tsao
Saeed Kamal A.
LandOfFree
Imidazolidinone compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazolidinone compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazolidinone compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3899544